BREAKING

CRDO Stock Plunges 10.4% to $104.73 as Three Analysts Slash Price Targets After Earnings 3 hours ago Chemours (CC) Shares Jump 9.4% as Analysts Raise Price Targets 3 hours ago GDS Holdings Misses Q4 EPS, Posts $0.35 Loss vs $12.31 Estimate Despite 8.6% Revenue Growth 3 hours ago BTDR Stock Jumps 16% to $9.52 on Sector Strength 3 hours ago RXO Stock Jumps 9.2% as Three Major Banks Raise Price Targets, Truist Sees 53% Upside 4 hours ago Academy Sports (ASO) Shares Plunge 10% as Q4 EPS of $1.97 Misses Estimates 4 hours ago Tencent Music Entertainment Gro (TME) Misses Q4 EPS Estimates by 85.6% 4 hours ago HUYA Inc. (HUYA) Misses Q4 EPS Estimates by 106.5% 4 hours ago Tencent Music Entertainment Group Q4 2025 4 hours ago CAAP Crushes Q4 Earnings Expectations with $0.65 EPS 4 hours ago CRDO Stock Plunges 10.4% to $104.73 as Three Analysts Slash Price Targets After Earnings 3 hours ago Chemours (CC) Shares Jump 9.4% as Analysts Raise Price Targets 3 hours ago GDS Holdings Misses Q4 EPS, Posts $0.35 Loss vs $12.31 Estimate Despite 8.6% Revenue Growth 3 hours ago BTDR Stock Jumps 16% to $9.52 on Sector Strength 3 hours ago RXO Stock Jumps 9.2% as Three Major Banks Raise Price Targets, Truist Sees 53% Upside 4 hours ago Academy Sports (ASO) Shares Plunge 10% as Q4 EPS of $1.97 Misses Estimates 4 hours ago Tencent Music Entertainment Gro (TME) Misses Q4 EPS Estimates by 85.6% 4 hours ago HUYA Inc. (HUYA) Misses Q4 EPS Estimates by 106.5% 4 hours ago Tencent Music Entertainment Group Q4 2025 4 hours ago CAAP Crushes Q4 Earnings Expectations with $0.65 EPS 4 hours ago

ADVERTISEMENT

Healthcare

82 articles

Tencent

Featured $ZBIO

Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25

Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $1.39 per share, a wider loss than the -$1.19 estimate (16.8% wider).

Newsdesk | March 16, 2026 | 1 min read

Tencent

$ANRO

Alto Neuroscience (ANRO) Reports FY25 Loss of $2.19/Share

Alto Neuroscience reports Q4 loss of $2.19/share, 434% wider than the $0.41 estimate, with zero revenue as clinical-stage biotech continues…

March 16, 2026 | 2 min read

$HQY

HealthEquity (HQY) Q4 Earnings Preview: 30% EPS Growth Expected Amid Analyst Price Target Cuts

HealthEquity reports Q4 fiscal 2026 on March 17 with Wall Street expecting 30% EPS growth, but recent price target cuts…

March 13, 2026 | 3 min read

Tencent

$NERV

Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings

**Minerva Neurosciences Reports Q4 2025 Results**

March 11, 2026 | 1 min read

Tencent

$VRCA

Verrica Pharmaceuticals inc (VRCA) Reports Q4 Earnings

**Verrica Pharmaceuticals Reports Q4 2025 Results**

March 11, 2026 | 1 min read

Tencent

$RAPP

Rapport Therapeutics Inc (RAPP) Reports a Wider Loss for Q4 2025

Rapport Therapeutics Inc (RAPP) posted a Q4 2025 gaap loss of $0.72 per share, wider than the -$0.67 expected loss…

March 11, 2026 | 2 min read

Tencent

$NUWE

Nuwellis Inc (NUWE) Reports Q4 Earnings

**Nuwellis Inc Reports Q4 2025 Results**

March 11, 2026 | 1 min read

Tencent

$TENX

Tenax Therapeutics Inc (TENX) Q4 Loss Widens, But Beats Estimates

**Tenax Therapeutics Narrows Q4 Loss, Beats Expectations**

March 11, 2026 | 1 min read

Tencent

$ULBI

Ultralife Corp (ULBI) Reports a net loss for Q4 FY25

Ultralife Corp (ULBI) reported Q4 2025 gaap earnings of $0.01 per share. No consensus estimate was available for comparison. Top-line…

March 10, 2026 | 1 min read

Tencent

$TARA

Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4

Protara Therapeutics, Inc. (TARA) posted a Q4 2025 gaap loss of $0.37 per share, wider than the -$0.31 expected loss…

March 10, 2026 | 1 min read